Hepatoblastoma and low birth weight: a trend or chance observation?

James Feusner1, J Plaschkes

  • 1Oncology, Children's Hospital Oakland, Oakland, California 94609, USA. jfeusner@mail.cho.org

Insights

Prematurity and low birth weight are linked to hepatoblastoma (HB), a childhood liver cancer. This study confirms earlier findings, highlighting risks for premature infants.

Area of Science:

  • Pediatric Oncology
  • Neonatology
  • Cancer Epidemiology

Background:

  • Previous research indicated a potential link between premature birth and hepatoblastoma (HB).
  • Hepatoblastoma is the most common pediatric liver cancer, often diagnosed in infancy.

Purpose of the Study:

  • To investigate and confirm the association between prematurity and hepatoblastoma.
  • To quantify the risk of hepatoblastoma in relation to birth status.

Main Methods:

  • Data collected via questionnaires from 105 children diagnosed with hepatoblastoma in a Children's Cancer Group (CCG) study.
  • Analysis of birth data, including gestational age and birth weight, for children with hepatoblastoma.

Main Results:

  • Prematurity (born before 37 weeks) showed a 2-fold increased risk for hepatoblastoma.
  • Low birth weight (under 1,000 grams) demonstrated a significantly higher 15-fold increased risk.
  • A subsequent CCG study with 36 HB children yielded similar findings.

Conclusions:

  • The study confirms a significant association between prematurity and hepatoblastoma.
  • Infants born prematurely or with low birth weight have a substantially elevated risk of developing hepatoblastoma.
  • These findings underscore the importance of monitoring high-risk infants for early detection of hepatoblastoma.
Abstract